Patent · US Active

Substances and methods for the use in prevention and/or treatment in Huntington's disease

US10406197B2 · kind B2 · utility

1Cited by
10References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 10, 2015
Grant dateSep 10, 2019
Priority date—
Expiry dateJul 11, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/2835
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are immunogenic peptides of the HTT protein and HTT specific antibodies for use in the prevention and/or treatment of Huntington's disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.